UNCY Earnings — Unicycive Therapeutics, Inc. Common Stock Post-ER Performance | BigEarnings
UNCY — Unicycive Therapeutics, Inc. Common Stock
XNAS · Healthcare · Biotechnology
Price$7.38
Market Cap$197.0M
P/E—
52W Range$3.71 – $11.00
Next Earnings2026-08-13
About Unicycive Therapeutics, Inc. Common Stock
Unicycive Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and commercializing therapies to address unmet medical needs, with a primary focus on kidney disease. The company is advancing two key product candidates: oxylanthanum carbonate (OLC), a phosphate binder for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis, and UNI-494, a drug candidate for the treatment of acute kidney injury.
